ITGR
KKR
KKR just added another trophy to the shelf
KKR said it agreed to buy Integer Holdings Corp. in an all-cash deal valuing the medical-device manufacturer at roughly $5.7 billion. The price tag works out to $127 a share, which is the kind of number that makes a boardroom stop mid-sip.
Why you should care
For KKR, this is classic private-equity behavior: find a business with steady demand, write a giant check, and try to make the spreadsheet math do parkour later. For shareholders of Integer, the takeaway is simpler — the company is being taken off the public market, and the headline premium is now the story.
- KKR gets a new platform in healthcare manufacturing.
- Integer investors get an all-cash exit instead of waiting around for the next earnings call.
- The deal adds to the M&A drumbeat, which is basically Wall Street’s version of “if you can’t beat it, buy it.”
Big picture
This is another reminder that big buyout shops still have a taste for companies with durable cash flows and boring-in-a-good-way businesses. And in this market, boring can be very, very valuable.